Matches in Wikidata for { <http://www.wikidata.org/entity/Q95323071> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q95323071 description "article scientifique publié en 2020" @default.
- Q95323071 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95323071 description "scientific article published on 01 May 2020" @default.
- Q95323071 description "wetenschappelijk artikel" @default.
- Q95323071 description "наукова стаття, опублікована 1 травня 2020" @default.
- Q95323071 name "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 name "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 type Item @default.
- Q95323071 label "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 label "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 prefLabel "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 prefLabel "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 P1104 Q95323071-B52E0CA7-57D2-442F-B07A-2846E6B1D170 @default.
- Q95323071 P1433 Q95323071-D867BC30-3203-46C5-8BDC-C6B6E2F1EEB4 @default.
- Q95323071 P1476 Q95323071-0F99A777-8D9D-4C67-8A9B-CE7542D2F25D @default.
- Q95323071 P2093 Q95323071-33CBA795-4D2A-4865-BEFE-7E33F1ECBB28 @default.
- Q95323071 P2093 Q95323071-CF58B778-3157-44E6-8145-375887963E4D @default.
- Q95323071 P2093 Q95323071-F19EE46D-2BC2-4149-AC94-34EDFD9C5FA3 @default.
- Q95323071 P304 Q95323071-8DB75EA6-F166-4542-BF08-993E174B2AE1 @default.
- Q95323071 P31 Q95323071-CA9C1B6C-C19E-4DDB-A6B1-98B9C97B0A44 @default.
- Q95323071 P356 Q95323071-A7B27001-99C8-4FB8-B200-EF7C49456582 @default.
- Q95323071 P433 Q95323071-FED75E9B-9D9E-4045-AB15-DBF73A95FDDC @default.
- Q95323071 P478 Q95323071-B700AA8A-5472-4959-AF8D-ED545715B135 @default.
- Q95323071 P577 Q95323071-CCE3035F-4ACB-483B-B0AB-66F8A069A1B0 @default.
- Q95323071 P698 Q95323071-BE13C946-80A5-4553-A0D7-08A22230FDFF @default.
- Q95323071 P921 Q95323071-DE032389-FEAC-4CB4-98D2-42A6BB89DC3E @default.
- Q95323071 P356 WNL.0000000000009449 @default.
- Q95323071 P698 32423986 @default.
- Q95323071 P1104 "+2" @default.
- Q95323071 P1433 Q1161692 @default.
- Q95323071 P1476 "Reader response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease" @default.
- Q95323071 P2093 "Clemens R Scherzer" @default.
- Q95323071 P2093 "Joseph J Locascio" @default.
- Q95323071 P2093 "Trond Riise" @default.
- Q95323071 P304 "898-899" @default.
- Q95323071 P31 Q13442814 @default.
- Q95323071 P356 "10.1212/WNL.0000000000009449" @default.
- Q95323071 P433 "20" @default.
- Q95323071 P478 "94" @default.
- Q95323071 P577 "2020-05-01T00:00:00Z" @default.
- Q95323071 P698 "32423986" @default.
- Q95323071 P921 Q11085 @default.